Scientific Presentations for Products in Development

Clovis Oncology presents data on its products in development at a variety of medical conferences. Our current and historic presentations are provided in the following links.

ARIEL4: An International, Randomised Phase 3 Study of Rucaparib vs Chemotherapy in BRCA1-or BRCA2-Mutated, Relapsed Ovarian Cancer (OC)

Presented at the 2017 International Meeting of the European Society of Gynaecological Oncology (ESGO)

Download the PDF